DEVELOPING COUNTRIES PATENT WAIVER COVID

Patent waiver will be of little use for India, developing countries

The compromise pact between the US, India, South Africa and EU around the patent waiver on Covid-19 medical tools could well turn out to be a ``missed opportunity’’ for domestic generic companies.